Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 28 for “"Tissue engineered heart valve"”.
-
Development of a completely biological tissue engineered heart valve.
In the United States alone, over 100,000 heart valve replacement procedures are performed each year, with approximately 45% of patients below age 65. While current mechanical and bioprosthetic heart valves are viable options, they have several limitations. The most significant limitation is for …
-
Optimizing Tissue-Engineered Heart Valve Design – An In-Silico Approach
… waste through your body. Specifically, the heart ensures oxygenated blood reaches tissues and deoxygenated blood reaches the lungs. In order to ensure one-way blood flow from the heart to the arteries, there are semilunar pulmonary and aortic valves from the heart to the pulmonary and aortic …
-
Biomimetic heterogeneous scaffolds for a layered tissue engineered heart valve
… and biochemical heterogeneity into synthetic tissue engineering scaffolds for heart valves. For a tissue engineered heart valve to work well, it must meet the mechanical demands of the natural heart valve and support healthy valve cell behavior. Natural heart valve leaflets have a …
-
Platform Technologies to Advance Clinically Relevant Tissue Engineered Heart Valve Products
Diseased heart valves are commonly replaced by mechanical, bioprosthetic, or allograft heart valves. These replacements provide major improvements in cardiac function and quality of life, but have significant limitations and eventually require surgical replacement within 15-20 years. These risks …
-
The development of a biodegradable scaffold for a tissue engineered heart valve
… a quality medical device to replace a failing heart valve. Presently, mechanical valves as well as donor tissue valves, either from humans or animals are used to replace failing heart valves. These valves although they can operate in the heart satisfactorily are not equal to the body replacing …
-
Development of a Tubular Biological Tissue-Engineered Heart Valve with Growth Potential
This thesis investigates tissue-engineered cardiovascular devices for pediatric patients and their function and growth potential in preclinical testing. Specifically, engineered tissue tubes were fabricated by entrapping dermal fibroblasts in a fibrin gel and allowing them to replace it with …
-
FABRICATION OF VASCULAR GRAFTS AND EFFECTS OF DESIGN PARAMETERS ON ARTERIAL REMODELING and DEVELOPMENT OF TISSUE ENGINEERED HEART VALVE FOR PERCUTANEOUS TRANSCATHETER DELIVERY
The growing incidence of ischemic heart disease and limitation of autologous grafts propel the development of tissue-engineered vascular grafts for bypass applications. Significant advancements were achieved with studies of grafts varying in materials, structures, and surface modification. However, …
-
Composition, turnover, and mechanics of extracellular matrix in developing, aging, and pathological valves for application in the design of age-specific tissue engineered heart valves
Debilitating valve disease necessitating valve replacement affects patients of all ages, all of whom would benefit from a tissue engineered heart valve with immunocompatibility, the ability of the valve to remodel in response to altered hemodynamics or patient growth, and physiologic mechanics. …
-
A PULSATILE BIOREACTOR FOR CONDITIONING TISSUE ENGINEERED HEART VALVES
Tissue engineered constructs with autologous adult stem cells capable of self-repair and growth are highly desired replacements for diseased heart valves. However, the current approaches have inadequate mechanical properties to withstand in vivo implantation. Therefore, our group hypothesized that …
-
Interactions between valvular cells: implications for heart valve tissue engineering
… in the US, including many abnormalities in heart valves. Tissue engineered heart valves (TEHVs) offer a solution for replacement or repair of affected valves. However, its therapeutic application is limited, and in ovine models, no TEHV has performed satisfactorily in vivo for longer than …
-
Development And Biomechanical Assessment Of Heart Valve Replacements Designed For In Utero Deployment
Congenital heart diseases (CHDs) account for nearly one third of all congenital defects. Patients born with complex congenital cardiac anomalies often require heart valve replacements in their lifetimes. These replacements are usually limited by issues related to durability, patient-prosthesis …
-
BIOMATERIALS AND BIOREACTORS FOR ENGINEERING LIVING AORTIC VALVE LEAFLETS
Heart valve disease is an increasing global burden affecting patients of all ages, ranging from pediatrics to the elderly. Unfortunately, there are currently no diagnostics for early detection or therapeutic treatment strategies. The only remedy for end-stage valve disease is a prosthetic heart …
-
Fabrication and Characterization of an Extracellular Matrix Hydrogel for Aortic Valve Applications
With an estimated 5 million people suffering from valve disease in the United, valve disease is currently the leading cause of cardiovascular disease. Each year, between 80,000 and 85,000 aortic valve replacements are performed in order to treat the stenotic heart valves. Despite this being a …
-
Fabrication and characterization of synthetic substrates for use in rigidity cell culture studies of valvular interstitial cells for aortic valve tissue engineering
… than 100,000 Americans each year undergo aortic valve (AV) replacement due to valve failure. An AV can become diseased, impairing the proper function of the valve. Common treatments for a defective valve are either replacement with a decellularized biologic or a synthetic valve. These treatments …
-
Fluid Flow Forces Regulate Fibrous Extracellular Matrix Protein Expression and Deposition Via A Rhoa/Rho Kinase Dependent Pathway During Atrioventricular Valve Development
Today, congenital heart defects are collectively the most common birth defect as well as the leading cause of birth defect related deaths, which often require surgical procedures, a lifetime of medications and preventative measures on the patient to maintain a working heart and a healthy body. As …
-
Dynamic Endothelialization of Aortic Heart Valve Scaffolds
… number one killer worldwide affecting both the heart and blood vessels. Valvular heart disease can arise from calcification, and structural deterioration resulting in a stenotic or regurgitant valve incapable of proper function. With approximately 275,000 valve replacements performed annually …
Page 1 of 2